

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 7.48308775 |
| 2 | cardiac myofibril assembly (GO:0055003) | 7.14246007 |
| 3 | actin-myosin filament sliding (GO:0033275) | 6.86212208 |
| 4 | muscle filament sliding (GO:0030049) | 6.86212208 |
| 5 | myofibril assembly (GO:0030239) | 6.57373569 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.94613763 |
| 7 | actin-mediated cell contraction (GO:0070252) | 5.83527667 |
| 8 | regulation of skeletal muscle contraction (GO:0014819) | 5.69480969 |
| 9 | plasma membrane repair (GO:0001778) | 5.50311824 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.24936574 |
| 11 | cardiac muscle cell development (GO:0055013) | 5.19467092 |
| 12 | response to muscle activity (GO:0014850) | 5.08925047 |
| 13 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.06852943 |
| 14 | actomyosin structure organization (GO:0031032) | 5.05904548 |
| 15 | cardiac muscle contraction (GO:0060048) | 5.05258025 |
| 16 | cardiac cell development (GO:0055006) | 4.95590200 |
| 17 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.90948383 |
| 18 | carnitine shuttle (GO:0006853) | 4.89016080 |
| 19 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.78534395 |
| 20 | actin filament-based movement (GO:0030048) | 4.71027670 |
| 21 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.69972731 |
| 22 | regulation of relaxation of muscle (GO:1901077) | 4.66178773 |
| 23 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.57595064 |
| 24 | cardiac muscle hypertrophy (GO:0003300) | 4.49559554 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 4.45118625 |
| 26 | adult heart development (GO:0007512) | 4.38375957 |
| 27 | striated muscle contraction (GO:0006941) | 4.34972228 |
| 28 | striated muscle hypertrophy (GO:0014897) | 4.31212598 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 4.29413330 |
| 30 | skeletal muscle fiber development (GO:0048741) | 4.26642694 |
| 31 | muscle tissue morphogenesis (GO:0060415) | 4.22351150 |
| 32 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.22223644 |
| 33 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.20220549 |
| 34 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.16162940 |
| 35 | myotube cell development (GO:0014904) | 4.14583911 |
| 36 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.12759362 |
| 37 | heart trabecula formation (GO:0060347) | 4.08375220 |
| 38 | regulation of sarcomere organization (GO:0060297) | 4.06327339 |
| 39 | tricarboxylic acid cycle (GO:0006099) | 4.03829428 |
| 40 | muscle fiber development (GO:0048747) | 3.95895086 |
| 41 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.95789718 |
| 42 | muscle hypertrophy (GO:0014896) | 3.93799566 |
| 43 | regulation of striated muscle contraction (GO:0006942) | 3.68171447 |
| 44 | * skeletal muscle tissue development (GO:0007519) | 3.62008759 |
| 45 | glycogen catabolic process (GO:0005980) | 3.59627353 |
| 46 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.57526092 |
| 47 | skeletal muscle contraction (GO:0003009) | 3.56041453 |
| 48 | muscle cell cellular homeostasis (GO:0046716) | 3.55769613 |
| 49 | carnitine transmembrane transport (GO:1902603) | 3.54405365 |
| 50 | skeletal muscle adaptation (GO:0043501) | 3.52286568 |
| 51 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.48251945 |
| 52 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.47253272 |
| 53 | glucan catabolic process (GO:0009251) | 3.44591531 |
| 54 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.44348789 |
| 55 | heart contraction (GO:0060047) | 3.42654685 |
| 56 | heart process (GO:0003015) | 3.42654685 |
| 57 | regulation of sequestering of triglyceride (GO:0010889) | 3.38485366 |
| 58 | regulation of myoblast differentiation (GO:0045661) | 3.36860569 |
| 59 | regulation of cell communication by electrical coupling (GO:0010649) | 3.36599032 |
| 60 | muscle cell fate commitment (GO:0042693) | 3.35323533 |
| 61 | regulation of the force of heart contraction (GO:0002026) | 3.33045831 |
| 62 | regulation of cardioblast differentiation (GO:0051890) | 3.29153795 |
| 63 | muscle organ development (GO:0007517) | 3.28375094 |
| 64 | muscle structure development (GO:0061061) | 3.28246024 |
| 65 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.28035226 |
| 66 | cellular polysaccharide catabolic process (GO:0044247) | 3.27433669 |
| 67 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26233029 |
| 68 | regulation of fatty acid oxidation (GO:0046320) | 3.25358678 |
| 69 | regulation of muscle system process (GO:0090257) | 3.23351915 |
| 70 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.21223301 |
| 71 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.21223301 |
| 72 | amino-acid betaine transport (GO:0015838) | 3.20924507 |
| 73 | carnitine transport (GO:0015879) | 3.20924507 |
| 74 | relaxation of muscle (GO:0090075) | 3.20476741 |
| 75 | striated muscle atrophy (GO:0014891) | 3.19721615 |
| 76 | striated muscle adaptation (GO:0014888) | 3.18601151 |
| 77 | muscle contraction (GO:0006936) | 3.17062918 |
| 78 | glycogen biosynthetic process (GO:0005978) | 3.14874504 |
| 79 | glucan biosynthetic process (GO:0009250) | 3.14874504 |
| 80 | striated muscle cell development (GO:0055002) | 3.13365179 |
| 81 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.12578502 |
| 82 | cardiac muscle adaptation (GO:0014887) | 3.12035927 |
| 83 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.12035927 |
| 84 | muscle hypertrophy in response to stress (GO:0003299) | 3.12035927 |
| 85 | positive regulation of myoblast differentiation (GO:0045663) | 3.10633557 |
| 86 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.10237001 |
| 87 | cell communication involved in cardiac conduction (GO:0086065) | 3.10038668 |
| 88 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.09791991 |
| 89 | negative regulation of heart growth (GO:0061117) | 3.09791991 |
| 90 | myoblast fusion (GO:0007520) | 3.08643529 |
| 91 | regulation of p38MAPK cascade (GO:1900744) | 3.07450251 |
| 92 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.05963183 |
| 93 | NADH metabolic process (GO:0006734) | 3.04919895 |
| 94 | trabecula formation (GO:0060343) | 3.04917631 |
| 95 | response to epinephrine (GO:0071871) | 3.04850674 |
| 96 | skeletal muscle tissue regeneration (GO:0043403) | 3.04824754 |
| 97 | negative regulation of protein localization to cell surface (GO:2000009) | 3.02652976 |
| 98 | cellular response to epinephrine stimulus (GO:0071872) | 3.02053670 |
| 99 | muscle system process (GO:0003012) | 2.98390201 |
| 100 | creatine metabolic process (GO:0006600) | 2.92814694 |
| 101 | positive regulation of fatty acid oxidation (GO:0046321) | 2.92662318 |
| 102 | polysaccharide catabolic process (GO:0000272) | 2.92350727 |
| 103 | venous blood vessel morphogenesis (GO:0048845) | 2.91778479 |
| 104 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.91461581 |
| 105 | * striated muscle tissue development (GO:0014706) | 2.90601755 |
| 106 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.90601546 |
| 107 | relaxation of cardiac muscle (GO:0055119) | 2.88954684 |
| 108 | desmosome organization (GO:0002934) | 2.88551890 |
| 109 | regulation of skeletal muscle fiber development (GO:0048742) | 2.84807461 |
| 110 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.84177582 |
| 111 | positive regulation of cation channel activity (GO:2001259) | 2.81216024 |
| 112 | regulation of myotube differentiation (GO:0010830) | 2.80067845 |
| 113 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.78492329 |
| 114 | muscle cell development (GO:0055001) | 2.76856960 |
| 115 | muscle adaptation (GO:0043500) | 2.76547313 |
| 116 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.76421103 |
| 117 | glycogen metabolic process (GO:0005977) | 2.76119735 |
| 118 | fatty acid beta-oxidation (GO:0006635) | 2.75549383 |
| 119 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.75500405 |
| 120 | regulation of cardiac muscle contraction (GO:0055117) | 2.75223978 |
| 121 | regulation of membrane repolarization (GO:0060306) | 2.72283536 |
| 122 | positive regulation of myotube differentiation (GO:0010831) | 2.72155166 |
| 123 | cardiac muscle cell action potential (GO:0086001) | 2.69639544 |
| 124 | intracellular lipid transport (GO:0032365) | 2.68751275 |
| 125 | regulation of heart rate (GO:0002027) | 2.68705344 |
| 126 | regulation of ATPase activity (GO:0043462) | 2.68346084 |
| 127 | regulation of ATP catabolic process (GO:1903289) | 2.68346084 |
| 128 | atrial septum morphogenesis (GO:0060413) | 2.66550684 |
| 129 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.66234609 |
| 130 | response to inactivity (GO:0014854) | 2.65000490 |
| 131 | coronary vasculature morphogenesis (GO:0060977) | 2.64845314 |
| 132 | regulation of muscle contraction (GO:0006937) | 2.62872000 |
| 133 | epithelial cell-cell adhesion (GO:0090136) | 2.62118854 |
| 134 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.61568892 |
| 135 | muscle atrophy (GO:0014889) | 2.61248764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.06753766 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.44331641 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.41269920 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.10354701 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.07725895 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.07725895 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.03208464 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.02111964 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.92161602 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.82681957 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.79354035 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.72110748 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.50503999 |
| 14 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.33911148 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.30211235 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.26801921 |
| 17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.25166053 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.21814003 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16268018 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.15630625 |
| 21 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.07168878 |
| 22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06619933 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89631653 |
| 24 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.88858973 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85010002 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.84605830 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83758058 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.81927350 |
| 29 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.78276566 |
| 30 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74025017 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.71218693 |
| 32 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.70153721 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68600967 |
| 34 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.66911487 |
| 35 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.63915371 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63599213 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61640731 |
| 38 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.60605360 |
| 39 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.60216564 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.59570061 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59496902 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.59333176 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58275786 |
| 44 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57900593 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56187552 |
| 46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54536608 |
| 47 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.52031964 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.51409833 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.49038162 |
| 50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.47397378 |
| 51 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47038331 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43419269 |
| 53 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.43386685 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42209009 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41444951 |
| 56 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40097727 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.40061973 |
| 58 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.39756030 |
| 59 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36820185 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33924719 |
| 61 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.29668525 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24042269 |
| 63 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23829124 |
| 64 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.21765097 |
| 65 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21759943 |
| 66 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21759943 |
| 67 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20889889 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20446851 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19504141 |
| 70 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18514366 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18306328 |
| 72 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18224180 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17504918 |
| 74 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15487522 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.15473503 |
| 76 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.15285856 |
| 77 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.15230363 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13108068 |
| 79 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12883399 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12376623 |
| 81 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10723271 |
| 82 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10539027 |
| 83 | GATA2_19941826_ChIP-Seq_K562_Human | 1.10444000 |
| 84 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09880550 |
| 85 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09697296 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09646466 |
| 87 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.08951227 |
| 88 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08794689 |
| 89 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08457378 |
| 90 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07530306 |
| 91 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.07515257 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.06957321 |
| 93 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.06170180 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05627575 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05222089 |
| 96 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04861047 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04465130 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04228343 |
| 99 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04216202 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03709924 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01470279 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01222099 |
| 103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01077354 |
| 104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00337649 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99722638 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99508781 |
| 107 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98547254 |
| 108 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97853634 |
| 109 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96118864 |
| 110 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96025488 |
| 111 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96011837 |
| 112 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95987096 |
| 113 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95622736 |
| 114 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95300568 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95091198 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93895149 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92700431 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92700431 |
| 119 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92167775 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91417824 |
| 121 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90776396 |
| 122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90410804 |
| 123 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90186574 |
| 124 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.88111805 |
| 125 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85942700 |
| 126 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85720745 |
| 127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84655795 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82822245 |
| 129 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81890860 |
| 130 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81397198 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81180106 |
| 132 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.80532125 |
| 133 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80179332 |
| 134 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80179332 |
| 135 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.79912602 |
| 136 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79450224 |
| 137 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79173002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.24556868 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.53216444 |
| 3 | MP0000751_myopathy | 4.17652680 |
| 4 | MP0003646_muscle_fatigue | 3.70263259 |
| 5 | MP0000749_muscle_degeneration | 3.52061489 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.40945465 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.40387264 |
| 8 | MP0005330_cardiomyopathy | 3.15209723 |
| 9 | MP0004087_abnormal_muscle_fiber | 2.87058331 |
| 10 | MP0000750_abnormal_muscle_regeneration | 2.56994595 |
| 11 | MP0002972_abnormal_cardiac_muscle | 2.52347678 |
| 12 | MP0010630_abnormal_cardiac_muscle | 2.49764964 |
| 13 | MP0004130_abnormal_muscle_cell | 2.45478081 |
| 14 | MP0008775_abnormal_heart_ventricle | 2.44969653 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.44445982 |
| 16 | MP0003828_pulmonary_edema | 2.41344830 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.32654020 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.32421615 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.24562974 |
| 20 | MP0001544_abnormal_cardiovascular_syste | 2.15635616 |
| 21 | MP0005385_cardiovascular_system_phenoty | 2.15635616 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.08357452 |
| 23 | MP0002269_muscular_atrophy | 1.98273261 |
| 24 | MP0004510_myositis | 1.92765691 |
| 25 | MP0005369_muscle_phenotype | 1.92628892 |
| 26 | MP0000759_abnormal_skeletal_muscle | 1.88674289 |
| 27 | MP0006138_congestive_heart_failure | 1.88539646 |
| 28 | MP0003137_abnormal_impulse_conducting | 1.87795308 |
| 29 | MP0003279_aneurysm | 1.84268459 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.83617267 |
| 31 | MP0004484_altered_response_of | 1.82388551 |
| 32 | MP0005275_abnormal_skin_tensile | 1.81424402 |
| 33 | MP0000747_muscle_weakness | 1.71796958 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.62931650 |
| 35 | MP0003950_abnormal_plasma_membrane | 1.54290574 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.48144407 |
| 37 | MP0000733_abnormal_muscle_development | 1.46131568 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.45930362 |
| 39 | MP0002127_abnormal_cardiovascular_syste | 1.45643092 |
| 40 | MP0005670_abnormal_white_adipose | 1.43896692 |
| 41 | MP0004272_abnormal_basement_membrane | 1.41639561 |
| 42 | MP0003567_abnormal_fetal_cardiomyocyte | 1.40261277 |
| 43 | MP0004085_abnormal_heartbeat | 1.37320210 |
| 44 | MP0000343_altered_response_to | 1.29534825 |
| 45 | MP0004233_abnormal_muscle_weight | 1.28715001 |
| 46 | MP0001661_extended_life_span | 1.28370952 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.26217126 |
| 48 | MP0002108_abnormal_muscle_morphology | 1.22618995 |
| 49 | MP0000266_abnormal_heart_morphology | 1.21947963 |
| 50 | MP0005503_abnormal_tendon_morphology | 1.21227071 |
| 51 | MP0000767_abnormal_smooth_muscle | 1.20062518 |
| 52 | MP0004185_abnormal_adipocyte_glucose | 1.19743222 |
| 53 | MP0001958_emphysema | 1.16540290 |
| 54 | MP0002128_abnormal_blood_circulation | 1.07440734 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.07247376 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.05942368 |
| 57 | MP0006054_spinal_hemorrhage | 0.97875022 |
| 58 | MP0003045_fibrosis | 0.92260145 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 0.90320858 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 0.83490862 |
| 61 | MP0009384_cardiac_valve_regurgitation | 0.82641146 |
| 62 | MP0002925_abnormal_cardiovascular_devel | 0.81820488 |
| 63 | MP0009278_abnormal_bone_marrow | 0.80699509 |
| 64 | MP0005165_increased_susceptibility_to | 0.79316655 |
| 65 | MP0003300_gastrointestinal_ulcer | 0.77768532 |
| 66 | MP0002234_abnormal_pharynx_morphology | 0.76215317 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.75610484 |
| 68 | MP0002971_abnormal_brown_adipose | 0.74556288 |
| 69 | MP0010030_abnormal_orbit_morphology | 0.74113571 |
| 70 | MP0005623_abnormal_meninges_morphology | 0.72924709 |
| 71 | MP0003252_abnormal_bile_duct | 0.72276444 |
| 72 | MP0001299_abnormal_eye_distance/ | 0.72049074 |
| 73 | MP0005023_abnormal_wound_healing | 0.71427897 |
| 74 | MP0001614_abnormal_blood_vessel | 0.69939381 |
| 75 | MP0002060_abnormal_skin_morphology | 0.69265575 |
| 76 | MP0000003_abnormal_adipose_tissue | 0.68783193 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 0.68272950 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.64250702 |
| 79 | MP0000762_abnormal_tongue_morphology | 0.63599956 |
| 80 | MP0005409_darkened_coat_color | 0.60948203 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 0.60282105 |
| 82 | MP0005319_abnormal_enzyme/_coenzyme | 0.59859128 |
| 83 | MP0005595_abnormal_vascular_smooth | 0.56068102 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.54973990 |
| 85 | MP0002088_abnormal_embryonic_growth/wei | 0.54426802 |
| 86 | MP0003984_embryonic_growth_retardation | 0.53760241 |
| 87 | MP0003091_abnormal_cell_migration | 0.51917674 |
| 88 | MP0009115_abnormal_fat_cell | 0.51280586 |
| 89 | MP0001784_abnormal_fluid_regulation | 0.51235084 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.51114498 |
| 91 | MP0002168_other_aberrant_phenotype | 0.50301174 |
| 92 | MP0000249_abnormal_blood_vessel | 0.49993301 |
| 93 | MP0003941_abnormal_skin_development | 0.49647491 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.48805442 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.47387133 |
| 96 | MP0005334_abnormal_fat_pad | 0.47108030 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 0.46882972 |
| 98 | MP0001853_heart_inflammation | 0.46645780 |
| 99 | MP0004858_abnormal_nervous_system | 0.45376276 |
| 100 | MP0005085_abnormal_gallbladder_physiolo | 0.45103723 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.44421817 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.44309697 |
| 103 | MP0002933_joint_inflammation | 0.43961524 |
| 104 | MP0001175_abnormal_lung_morphology | 0.43928217 |
| 105 | MP0005083_abnormal_biliary_tract | 0.43441562 |
| 106 | MP0005451_abnormal_body_composition | 0.43211974 |
| 107 | MP0002133_abnormal_respiratory_system | 0.43204980 |
| 108 | MP0005388_respiratory_system_phenotype | 0.43204980 |
| 109 | MP0005266_abnormal_metabolism | 0.42145247 |
| 110 | MP0003385_abnormal_body_wall | 0.42057749 |
| 111 | MP0004270_analgesia | 0.40515142 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.40390034 |
| 113 | MP0008004_abnormal_stomach_pH | 0.39637597 |
| 114 | MP0001849_ear_inflammation | 0.39237019 |
| 115 | MP0002114_abnormal_axial_skeleton | 0.39004621 |
| 116 | MP0004134_abnormal_chest_morphology | 0.38250744 |
| 117 | MP0000462_abnormal_digestive_system | 0.38069494 |
| 118 | MP0005166_decreased_susceptibility_to | 0.38045601 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.36370280 |
| 120 | MP0005248_abnormal_Harderian_gland | 0.35307953 |
| 121 | MP0003948_abnormal_gas_homeostasis | 0.33926681 |
| 122 | MP0000579_abnormal_nail_morphology | 0.33097226 |
| 123 | MP0002998_abnormal_bone_remodeling | 0.31159871 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.29695414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.75836217 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.83879564 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.39140152 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 5.38714136 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 5.34047855 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.20143269 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 5.17908331 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.95612685 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 4.94495684 |
| 10 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.92747702 |
| 11 | Increased connective tissue (HP:0009025) | 4.84033505 |
| 12 | Subaortic stenosis (HP:0001682) | 4.78493426 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.78493426 |
| 14 | Lipoatrophy (HP:0100578) | 4.73314332 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.69022139 |
| 16 | Atrial fibrillation (HP:0005110) | 4.60765811 |
| 17 | Primary atrial arrhythmia (HP:0001692) | 4.24569493 |
| 18 | Myoglobinuria (HP:0002913) | 4.10793472 |
| 19 | Supraventricular tachycardia (HP:0004755) | 4.05774245 |
| 20 | Supraventricular arrhythmia (HP:0005115) | 4.03388548 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 4.00865607 |
| 22 | Muscle fiber inclusion bodies (HP:0100299) | 3.86189093 |
| 23 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.86031058 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 3.79499255 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 3.76808726 |
| 26 | Difficulty running (HP:0009046) | 3.60568774 |
| 27 | Syncope (HP:0001279) | 3.52755712 |
| 28 | Calcaneovalgus deformity (HP:0001848) | 3.41138444 |
| 29 | Ventricular arrhythmia (HP:0004308) | 3.26792140 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.20548824 |
| 31 | Palpitations (HP:0001962) | 3.19953085 |
| 32 | Bundle branch block (HP:0011710) | 3.17997986 |
| 33 | Nemaline bodies (HP:0003798) | 3.15601201 |
| 34 | Broad metatarsal (HP:0001783) | 3.08725935 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 3.05708460 |
| 36 | Deformed tarsal bones (HP:0008119) | 3.03784740 |
| 37 | Prolonged QT interval (HP:0001657) | 3.03086445 |
| 38 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.00965079 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.99287227 |
| 40 | Absent phalangeal crease (HP:0006109) | 2.91701078 |
| 41 | Difficulty climbing stairs (HP:0003551) | 2.88611703 |
| 42 | Atrioventricular block (HP:0001678) | 2.83224083 |
| 43 | Heart block (HP:0012722) | 2.78253714 |
| 44 | Myotonia (HP:0002486) | 2.77899289 |
| 45 | Malignant hyperthermia (HP:0002047) | 2.74676174 |
| 46 | Abnormal atrioventricular conduction (HP:0005150) | 2.71842667 |
| 47 | Distal arthrogryposis (HP:0005684) | 2.65508031 |
| 48 | Bulbar palsy (HP:0001283) | 2.64880487 |
| 49 | Round ear (HP:0100830) | 2.60105539 |
| 50 | Hypoplastic ischia (HP:0003175) | 2.57055691 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.56445322 |
| 52 | Protrusio acetabuli (HP:0003179) | 2.50426429 |
| 53 | Hypoglycemic coma (HP:0001325) | 2.49915753 |
| 54 | Distal lower limb muscle weakness (HP:0009053) | 2.49637660 |
| 55 | Ankle contracture (HP:0006466) | 2.46191957 |
| 56 | Neck muscle weakness (HP:0000467) | 2.45566605 |
| 57 | Abnormal finger flexion creases (HP:0006143) | 2.44227623 |
| 58 | Facial diplegia (HP:0001349) | 2.38943024 |
| 59 | Scapular winging (HP:0003691) | 2.34759482 |
| 60 | Abnormality of the calcaneus (HP:0008364) | 2.30083656 |
| 61 | Spinal rigidity (HP:0003306) | 2.30020776 |
| 62 | Abnormality of the ischium (HP:0003174) | 2.27606814 |
| 63 | Abnormality of the foot musculature (HP:0001436) | 2.27388403 |
| 64 | Muscle stiffness (HP:0003552) | 2.22413671 |
| 65 | Distal lower limb amyotrophy (HP:0008944) | 2.20328738 |
| 66 | Aortic aneurysm (HP:0004942) | 2.17523817 |
| 67 | Ventricular fibrillation (HP:0001663) | 2.17447121 |
| 68 | Foot dorsiflexor weakness (HP:0009027) | 2.15568437 |
| 69 | Aneurysm (HP:0002617) | 2.15467827 |
| 70 | Ketoacidosis (HP:0001993) | 2.13644603 |
| 71 | Fatigable weakness (HP:0003473) | 2.12960378 |
| 72 | Abnormality of the neuromuscular junction (HP:0003398) | 2.12960378 |
| 73 | Generalized muscle weakness (HP:0003324) | 2.12417936 |
| 74 | Palmoplantar keratoderma (HP:0000982) | 2.12393385 |
| 75 | Lower limb amyotrophy (HP:0007210) | 2.10166415 |
| 76 | Limited hip movement (HP:0008800) | 2.09804878 |
| 77 | Hyperkalemia (HP:0002153) | 2.08793432 |
| 78 | Areflexia of lower limbs (HP:0002522) | 2.08404811 |
| 79 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.07155176 |
| 80 | Weak cry (HP:0001612) | 2.04964605 |
| 81 | Fetal akinesia sequence (HP:0001989) | 2.04763512 |
| 82 | Frequent falls (HP:0002359) | 2.03886116 |
| 83 | Lymphangioma (HP:0100764) | 2.03288123 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03116364 |
| 85 | Myopathic facies (HP:0002058) | 2.02336395 |
| 86 | EMG: neuropathic changes (HP:0003445) | 2.01516521 |
| 87 | Ulnar deviation of the wrist (HP:0003049) | 2.01237509 |
| 88 | Popliteal pterygium (HP:0009756) | 1.99737895 |
| 89 | Sudden cardiac death (HP:0001645) | 1.99151692 |
| 90 | Waddling gait (HP:0002515) | 1.98193848 |
| 91 | Aortic dissection (HP:0002647) | 1.97674178 |
| 92 | Hip contracture (HP:0003273) | 1.96912803 |
| 93 | Limb-girdle muscle atrophy (HP:0003797) | 1.96562062 |
| 94 | Abnormal EKG (HP:0003115) | 1.94883600 |
| 95 | Conjunctival hamartoma (HP:0100780) | 1.90057526 |
| 96 | Premature rupture of membranes (HP:0001788) | 1.87719656 |
| 97 | Slender build (HP:0001533) | 1.87501646 |
| 98 | Muscular dystrophy (HP:0003560) | 1.87350040 |
| 99 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.85849124 |
| 100 | Left ventricular hypertrophy (HP:0001712) | 1.84989499 |
| 101 | Pulmonary artery stenosis (HP:0004415) | 1.83489827 |
| 102 | Steppage gait (HP:0003376) | 1.79050765 |
| 103 | Congestive heart failure (HP:0001635) | 1.77202758 |
| 104 | Rimmed vacuoles (HP:0003805) | 1.76727167 |
| 105 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74880252 |
| 106 | Hyperglycemia (HP:0003074) | 1.72424784 |
| 107 | Proximal amyotrophy (HP:0007126) | 1.69060500 |
| 108 | Gowers sign (HP:0003391) | 1.68972003 |
| 109 | Atrophic scars (HP:0001075) | 1.67950062 |
| 110 | Rectal prolapse (HP:0002035) | 1.66785710 |
| 111 | Testicular atrophy (HP:0000029) | 1.65474400 |
| 112 | Generalized amyotrophy (HP:0003700) | 1.64671750 |
| 113 | Shallow orbits (HP:0000586) | 1.63529623 |
| 114 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.63516386 |
| 115 | Limb-girdle muscle weakness (HP:0003325) | 1.60414500 |
| 116 | Metatarsus adductus (HP:0001840) | 1.60044122 |
| 117 | Hypoalphalipoproteinemia (HP:0003233) | 1.57813488 |
| 118 | Ketosis (HP:0001946) | 1.57507701 |
| 119 | Neonatal death (HP:0003811) | 1.56773371 |
| 120 | Hamartoma of the eye (HP:0010568) | 1.56454492 |
| 121 | Mitral valve prolapse (HP:0001634) | 1.54998634 |
| 122 | Long clavicles (HP:0000890) | 1.54646337 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.54481225 |
| 124 | Progressive muscle weakness (HP:0003323) | 1.54068876 |
| 125 | Ulnar deviation of finger (HP:0009465) | 1.53042607 |
| 126 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.47450211 |
| 127 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.47450211 |
| 128 | Ragged-red muscle fibers (HP:0003200) | 1.45984885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.49685453 |
| 2 | OBSCN | 4.88412119 |
| 3 | TRIB3 | 3.59185660 |
| 4 | PKN2 | 3.39373917 |
| 5 | DMPK | 3.03744543 |
| 6 | MYLK | 2.78740592 |
| 7 | PHKG1 | 2.29462951 |
| 8 | PHKG2 | 2.29462951 |
| 9 | LMTK2 | 2.21078205 |
| 10 | TIE1 | 2.18477040 |
| 11 | PIK3CA | 1.97362195 |
| 12 | RIPK1 | 1.83764200 |
| 13 | TGFBR2 | 1.77377973 |
| 14 | STK24 | 1.72286748 |
| 15 | PDK3 | 1.69579890 |
| 16 | PDK4 | 1.69579890 |
| 17 | SIK1 | 1.68485355 |
| 18 | LATS1 | 1.59916191 |
| 19 | PDGFRA | 1.51882824 |
| 20 | ZAK | 1.47310388 |
| 21 | ERN1 | 1.41878791 |
| 22 | INSRR | 1.37431085 |
| 23 | MAP2K3 | 1.36205849 |
| 24 | MAP3K10 | 1.35241979 |
| 25 | PTK6 | 1.34624373 |
| 26 | TRPM7 | 1.34136523 |
| 27 | EPHB1 | 1.33741288 |
| 28 | BCKDK | 1.33721594 |
| 29 | MAP3K7 | 1.32667366 |
| 30 | FGFR4 | 1.27008717 |
| 31 | PIK3CG | 1.17618845 |
| 32 | FLT3 | 1.13271083 |
| 33 | NEK1 | 1.12613484 |
| 34 | ILK | 1.11708207 |
| 35 | NEK9 | 1.11617818 |
| 36 | MUSK | 1.06249806 |
| 37 | MAP3K3 | 1.04674133 |
| 38 | PDK2 | 1.00538383 |
| 39 | PRKD1 | 0.99852258 |
| 40 | PRKAA2 | 0.98179504 |
| 41 | CAMK1D | 0.98119964 |
| 42 | MAPK7 | 0.97653506 |
| 43 | EPHA3 | 0.94529568 |
| 44 | LRRK2 | 0.88718731 |
| 45 | FGFR3 | 0.87875028 |
| 46 | MAP3K6 | 0.87226535 |
| 47 | STK4 | 0.86887758 |
| 48 | MOS | 0.86581350 |
| 49 | KDR | 0.86406966 |
| 50 | CDK12 | 0.84530129 |
| 51 | LIMK1 | 0.82646598 |
| 52 | EEF2K | 0.76505861 |
| 53 | ROCK1 | 0.76255110 |
| 54 | JAK1 | 0.74119689 |
| 55 | STK3 | 0.73356408 |
| 56 | MAPK12 | 0.72998337 |
| 57 | MTOR | 0.72093639 |
| 58 | CAMK1G | 0.70140819 |
| 59 | CDC42BPA | 0.70115071 |
| 60 | STK10 | 0.69738651 |
| 61 | PDGFRB | 0.69638041 |
| 62 | LATS2 | 0.69411192 |
| 63 | MAP2K4 | 0.68643554 |
| 64 | CAMK2G | 0.68326330 |
| 65 | PRKAA1 | 0.68207530 |
| 66 | PAK3 | 0.64203073 |
| 67 | MARK2 | 0.64131655 |
| 68 | KSR2 | 0.62659804 |
| 69 | SGK2 | 0.61987212 |
| 70 | PINK1 | 0.61049875 |
| 71 | MAP2K6 | 0.60235673 |
| 72 | MAPKAPK3 | 0.58435719 |
| 73 | NLK | 0.56108924 |
| 74 | MAP3K13 | 0.56091923 |
| 75 | MAP3K5 | 0.54887787 |
| 76 | FGFR2 | 0.54841480 |
| 77 | MAPK4 | 0.53734197 |
| 78 | EPHB2 | 0.53659557 |
| 79 | MET | 0.53543900 |
| 80 | MAP3K1 | 0.53536151 |
| 81 | ZAP70 | 0.51606986 |
| 82 | CAMK2D | 0.51598974 |
| 83 | RPS6KC1 | 0.51376714 |
| 84 | RPS6KL1 | 0.51376714 |
| 85 | PAK2 | 0.51338040 |
| 86 | CAMK1 | 0.51237836 |
| 87 | TYK2 | 0.50207673 |
| 88 | MAP2K1 | 0.49314987 |
| 89 | RPS6KA6 | 0.48969646 |
| 90 | ERBB3 | 0.48940036 |
| 91 | GRK7 | 0.48080081 |
| 92 | AKT3 | 0.47249812 |
| 93 | PTK2 | 0.47034936 |
| 94 | CSK | 0.46867169 |
| 95 | MARK1 | 0.46823748 |
| 96 | MST1R | 0.46721242 |
| 97 | CAMK4 | 0.46131876 |
| 98 | JAK3 | 0.44637492 |
| 99 | STK38L | 0.44617949 |
| 100 | DYRK1B | 0.44570785 |
| 101 | WNK1 | 0.44437828 |
| 102 | RPS6KA2 | 0.44389234 |
| 103 | TGFBR1 | 0.43903008 |
| 104 | FGFR1 | 0.43629175 |
| 105 | TBK1 | 0.42751941 |
| 106 | RET | 0.41224425 |
| 107 | PRKG1 | 0.41152696 |
| 108 | PAK4 | 0.40883813 |
| 109 | MARK3 | 0.40738629 |
| 110 | JAK2 | 0.40639704 |
| 111 | MAP4K1 | 0.40316354 |
| 112 | MAPK11 | 0.39773217 |
| 113 | PTK2B | 0.39310208 |
| 114 | DDR2 | 0.38962121 |
| 115 | CDK6 | 0.38572161 |
| 116 | FER | 0.38523739 |
| 117 | PRKCH | 0.36930978 |
| 118 | ITK | 0.36927094 |
| 119 | DAPK3 | 0.36135950 |
| 120 | ICK | 0.35854444 |
| 121 | CHUK | 0.35509891 |
| 122 | ROCK2 | 0.35101472 |
| 123 | AKT2 | 0.34848417 |
| 124 | STK38 | 0.34688981 |
| 125 | KSR1 | 0.34412434 |
| 126 | SGK223 | 0.31926862 |
| 127 | SGK494 | 0.31926862 |
| 128 | SGK3 | 0.31609982 |
| 129 | FRK | 0.29310401 |
| 130 | EPHA2 | 0.29221883 |
| 131 | NUAK1 | 0.28664161 |
| 132 | BMX | 0.28375785 |
| 133 | PRKG2 | 0.27961736 |
| 134 | CAMK2A | 0.27466253 |
| 135 | TAOK2 | 0.24538557 |
| 136 | PDPK1 | 0.23586332 |
| 137 | CAMK2B | 0.23247378 |
| 138 | RAF1 | 0.23019814 |
| 139 | GSK3A | 0.22005321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.30240136 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.81064404 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.67088240 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.21640584 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.88606401 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.77534403 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.56043789 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.54279391 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.45260366 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.19630943 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99418239 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99286166 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84835932 |
| 14 | Insulin resistance_Homo sapiens_hsa04931 | 1.82044578 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.69759718 |
| 16 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.69454963 |
| 17 | Lysine degradation_Homo sapiens_hsa00310 | 1.63778604 |
| 18 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59597178 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50469259 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42280586 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.40552779 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.36089750 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.26482107 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18733224 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.16482914 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15873407 |
| 27 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15132926 |
| 28 | Amoebiasis_Homo sapiens_hsa05146 | 1.14421084 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13837889 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.12049384 |
| 31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11894309 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10430696 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08902829 |
| 34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06198974 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04839690 |
| 36 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04224397 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.03055907 |
| 38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00460356 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97886281 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97813179 |
| 41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96369768 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92322678 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90368894 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89505762 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87219889 |
| 46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.86618245 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85250142 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84021806 |
| 49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79766176 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.79732486 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79626146 |
| 52 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78768321 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.77658014 |
| 54 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72260336 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71997944 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71793464 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71108467 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70935088 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70310443 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.69801551 |
| 61 | Glioma_Homo sapiens_hsa05214 | 0.69741213 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69556313 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68077091 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67390255 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67033327 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66192558 |
| 67 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65891916 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65215414 |
| 69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64531245 |
| 70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.63150237 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61863238 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61275100 |
| 73 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60385381 |
| 74 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59960884 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59315929 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.59033158 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58289666 |
| 78 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57317250 |
| 79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57273969 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.56310320 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55599750 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55410948 |
| 83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55385701 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.55083924 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52840014 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52559704 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51242005 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.50863381 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.50408330 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.50176643 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49866259 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49655852 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49448890 |
| 94 | Malaria_Homo sapiens_hsa05144 | 0.48936996 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48338154 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48233412 |
| 97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.47846574 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46733123 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45665700 |
| 100 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44671692 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44653862 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44160233 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43220829 |
| 104 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42030287 |
| 105 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41858778 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.41396315 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40047018 |
| 108 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39943828 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.39303791 |
| 110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39203724 |
| 111 | Long-term depression_Homo sapiens_hsa04730 | 0.38215323 |
| 112 | Axon guidance_Homo sapiens_hsa04360 | 0.37921562 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36976295 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36418386 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36286757 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35369068 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35175985 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.34278036 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.33435328 |
| 120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32478798 |
| 121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31491411 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30722684 |
| 123 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.30159006 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29663802 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.28782264 |
| 126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.28411239 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27384129 |
| 128 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.26149431 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25872529 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25531670 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25389300 |
| 132 | Salmonella infection_Homo sapiens_hsa05132 | 0.24611305 |
| 133 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.24098919 |
| 134 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.23545257 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23333816 |

